Analysts/Institutional Investor Meet/Con. Call Updates

Ref: Akums/Exchange/2026-27/63 November 03, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Audio recording of Earning/ Quarterly Conference Call held on the un-audited financial results for the quarter and half year ended on September 30, 2026 Respected Sir/Ma’am, Pursuant to the Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of audio recording of Earning/ Quarterly Conference Call held today i.e. Tuesday, November 03, 2026 at 12:00 PM (IST) on the un-audited financial results of Akums Drugs and Pharmaceuticals Limited (“the Company”) for the quarter and half year ended on September 30, 2026. Link: https://www.akums.in/wp-content/uploads/2026/11/Q2-FY27-Audio-Recording.mp3 The transcript for the said call will be shared with the Stock Exchanges and will also be uploaded on the Company’s website at https://www.akums.in/investors/investors-meet/ in due course. This is for your kind information and record. Thanking You Yours Faithfully For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer